Oyster Point Pharma Inc (OYST) Stock
OYST is no longer traded. Oyster Point Pharma was delisted from the Nasdaq in December 2022.
Prices on this page are historical; the last trade was December 30, 2022 at $11.17.
Oyster Point Pharma stock price history
OYST final trading statistics
- Final close
- $11.17
- Final trading day
- Dec 30, 2022
- Market cap at delisting
- $299.85M
- Shares outstanding
- 26.84M
- Final 52-week range
- $3.46 – $19.00
- Avg. volume (final 3 mo.)
- 410,603
- All-time high (split-adj.)
- $40.96 · Feb 2020
- All-time low (split-adj.)
- $3.60 · Jun 2022
- Return since IPO
- -40.5%
- Beta
- 1.28
- Book value / share
- -$0.83
- Price / book
- -13.51
Oyster Point Pharma annual financials
| Fiscal year | Revenue | Net income | EPS |
|---|---|---|---|
| FY2021 | $24.54M | -$100.7M | -$3.87 |
| FY2020 | $0.00 | -$70.5M | -$2.92 |
| FY2019 | $0.00 | -$45.7M | -$9.51 |
| FY2018 | $0.00 | -$16.5M | — |
| FY2017 | $0.00 | -$6.6M | — |
Last five fiscal years reported before the delisting; fiscal year ending December. EPS is adjusted (non-GAAP) EPS as reported. Source: company filings via EODHD.
About Oyster Point Pharma Inc
As of January 3, 2023, Oyster Point Pharma, Inc. was acquired by Viatris Inc. Oyster Point Pharma, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of pharmaceutical therapies to treat ophthalmic diseases in the United States. The company's product candidate is TYRVAYA, a nicotinic acetylcholine receptor agonist for the treatment of signs and symptoms of dry eye disease. It is also developing TYRVAYA that is in Phase II clinical trial for the treatment of for neurotrophic keratopathy. The company was incorporated in 2015 and is headquartered in Princeton, New Jersey.
Oyster Point Pharma stock FAQ
What happened to Oyster Point Pharma stock?
Oyster Point Pharma stock was delisted from the Nasdaq. Its final close was $11.17 on December 30, 2022.
Is OYST stock still trading?
No. OYST was delisted from the Nasdaq in December 2022 and no longer trades on a U.S. exchange.
What was the last price of OYST stock?
OYST closed at $11.17 on its final trading day, December 30, 2022, for a market value of about $299.85M.
What were Oyster Point Pharma's revenue and earnings in its last full fiscal year?
Oyster Point Pharma reported revenue of $24.54M and net income of -$100.7M in fiscal 2021, its last full year as a public company.
When did Oyster Point Pharma go public?
Oyster Point Pharma Inc stock began trading on October 31, 2019.